1. Academic Validation
  2. GSK-3-selective inhibitors derived from Tyrian purple indirubins

GSK-3-selective inhibitors derived from Tyrian purple indirubins

  • Chem Biol. 2003 Dec;10(12):1255-66. doi: 10.1016/j.chembiol.2003.11.010.
Laurent Meijer 1 Alexios-Leandros Skaltsounis Prokopios Magiatis Panagiotis Polychronopoulos Marie Knockaert Maryse Leost Xiaozhou P Ryan Claudia Alin Vonica Ali Brivanlou Rana Dajani Claudia Crovace Cataldo Tarricone Andrea Musacchio S Mark Roe Laurence Pearl Paul Greengard
Affiliations

Affiliation

  • 1 CNRS, Cell Cycle Group, Station Biologique, BP 74, 29682 Roscoff cedex, Bretagne, France. meijer@sb-roscoff.fr
Abstract

Gastropod mollusks have been used for over 2500 years to produce the "Tyrian purple" dye made famous by the Phoenicians. This dye is constituted of mixed bromine-substituted indigo and indirubin isomers. Among these, the new natural product 6-bromoindirubin and its synthetic, cell-permeable derivative, 6-bromoindirubin-3'-oxime (BIO), display remarkable selective inhibition of glycogen synthase kinase-3 (GSK-3). Cocrystal structure of GSK-3beta/BIO and CDK5/p25/indirubin-3'-oxime were resolved, providing a detailed view of indirubins' interactions within the ATP binding pocket of these kinases. BIO but not 1-methyl-BIO, its kinase inactive analog, also inhibited the phosphorylation on Tyr276/216, a GSK-3alpha/beta activation site. BIO but not 1-methyl-BIO reduced beta-catenin phosphorylation on a GSK-3-specific site in cellular models. BIO but not 1-methyl-BIO closely mimicked Wnt signaling in Xenopus embryos. 6-bromoindirubins thus provide a new scaffold for the development of selective and potent pharmacological inhibitors of GSK-3.

Figures
Products